ESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove

ESTEVE CDMO, a global pure-play CDMO specializing in the development and manufacture of small-molecule APIs and pharmaceutical intermediates, has approved an additional $17.5 million capacity expansion and containment capabilities at…

Continue ReadingESTEVE CDMO expands U.S. capacity with additional $17.5 million investment in Morton Grove

CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium

CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more confident decision-making, today announced the full scientific program for the 2026 'From Insight…

Continue ReadingCN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium